High Net Worth Advisory Group LLC Erasca, Inc. Transaction History

High Net Worth Advisory Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 24, 2022	BUY	$5.82 - $10.68 $5,820 - $10,680	1,000 New	1,000 $8,000
Q1 2022 May 13, 2022	SELL	$8.6 - $15.48 $1,720 - $3,096	-200 Closed	0 $0
Q4 2021 Aug 10, 2022	SELL	$12.51 - $22.75 $3,753 - $6,825	-300 Reduced 60.0%	200 $3,000
Q4 2021 Apr 27, 2022	BUY	$12.51 - $22.75 $6,255 - $11,375	500 New	500 $6,000

117

74.3M

7.1K

40.1K

Ticker ERAS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 122,147,000
Market Cap $287M
Description
Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...

Get notified when there are updates to the investment portfolio of High Net Worth Advisory Group LLC, based on Form 13F filings with the SEC.

Stay updated on High Net Worth Advisory Group LLC with notifications on news.